The introduction of Retatrutide ZPHC, at a strength of 120mg, is generating considerable buzz within the healthcare community. This groundbreaking dual GIP and GLP-1 agonist medication suggests to deliver impressive improvements in weight loss compared to existing therapies. Early research data h